Teva Changes Its Tune On Substitutable Generic Advair
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva is aggressively developing a fully substitutable generic version of Advair and other AB-rated respiratory products now that FDA has released draft guidance on bioequivalence requirements for the inhaled respiratory drug.